Medical Properties Trust (NYSE:MPW) had its price target boosted by Mitsubishi UFJ Financial Group to $17.00 in a research report sent to investors on Monday, The Fly reports. They currently have a neutral rating on the real estate investment trust’s stock.
Other equities research analysts have also issued research reports about the company. JPMorgan Chase & Co. raised Medical Properties Trust from a neutral rating to an overweight rating in a research note on Wednesday, December 19th. Wells Fargo & Co raised Medical Properties Trust from an underperform rating to a market perform rating and boosted their price target for the stock from $13.50 to $17.50 in a research note on Tuesday, December 11th. SunTrust Banks lowered Medical Properties Trust from a buy rating to a hold rating in a research note on Tuesday, December 18th. Zacks Investment Research raised Medical Properties Trust from a sell rating to a hold rating in a research note on Wednesday, November 7th. Finally, Stifel Nicolaus set a $14.00 price target on Medical Properties Trust and gave the stock a hold rating in a research note on Thursday, November 1st. Seven research analysts have rated the stock with a hold rating and three have given a buy rating to the stock. The stock presently has an average rating of Hold and a consensus price target of $15.42.
NYSE MPW opened at $18.49 on Monday. The company has a debt-to-equity ratio of 0.89, a quick ratio of 4.92 and a current ratio of 5.22. Medical Properties Trust has a 12-month low of $11.97 and a 12-month high of $18.56. The company has a market cap of $6.84 billion, a price-to-earnings ratio of 13.50, a price-to-earnings-growth ratio of 6.42 and a beta of 0.72.
Medical Properties Trust (NYSE:MPW) last released its earnings results on Thursday, February 7th. The real estate investment trust reported $0.31 earnings per share (EPS) for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.31. The company had revenue of $180.60 million for the quarter, compared to analysts’ expectations of $179.68 million. Medical Properties Trust had a return on equity of 8.83% and a net margin of 129.59%. The firm’s quarterly revenue was down 11.9% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.37 EPS. As a group, equities research analysts forecast that Medical Properties Trust will post 1.44 EPS for the current year.
In other Medical Properties Trust news, insider Emmett E. Mclean sold 50,000 shares of the business’s stock in a transaction on Tuesday, December 4th. The stock was sold at an average price of $17.40, for a total value of $870,000.00. Following the completion of the transaction, the insider now directly owns 913,965 shares in the company, valued at approximately $15,902,991. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Michael G. Stewart sold 5,800 shares of the business’s stock in a transaction on Tuesday, December 4th. The shares were sold at an average price of $17.39, for a total value of $100,862.00. Following the completion of the transaction, the director now owns 225,239 shares of the company’s stock, valued at $3,916,906.21. The disclosure for this sale can be found here. In the last ninety days, insiders sold 98,865 shares of company stock worth $1,693,493. 0.83% of the stock is owned by corporate insiders.
Several hedge funds have recently added to or reduced their stakes in MPW. Laurel Wealth Advisors LLC acquired a new stake in shares of Medical Properties Trust during the 4th quarter worth $32,000. Victory Capital Management Inc. acquired a new stake in shares of Medical Properties Trust during the 4th quarter worth $45,000. Nvwm LLC acquired a new stake in shares of Medical Properties Trust during the 4th quarter worth $49,000. Whittier Trust Co. of Nevada Inc. increased its holdings in shares of Medical Properties Trust by 32.9% during the 4th quarter. Whittier Trust Co. of Nevada Inc. now owns 3,322 shares of the real estate investment trust’s stock worth $53,000 after buying an additional 822 shares during the last quarter. Finally, Parallel Advisors LLC increased its holdings in shares of Medical Properties Trust by 22.0% during the 4th quarter. Parallel Advisors LLC now owns 3,759 shares of the real estate investment trust’s stock worth $60,000 after buying an additional 679 shares during the last quarter. Institutional investors and hedge funds own 76.61% of the company’s stock.
About Medical Properties Trust
Medical Properties Trust, Inc is a self-advised real estate investment trust formed to capitalize on the changing trends in healthcare delivery by acquiring and developing net-leased healthcare facilities. MPT's financing model helps facilitate acquisitions and recapitalizations and allows operators of hospitals and other healthcare facilities to unlock the value of their real estate assets to fund facility improvements, technology upgrades and other investments in operations.
Featured Article: What are the risks of holding treasury bonds?
Receive News & Ratings for Medical Properties Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medical Properties Trust and related companies with MarketBeat.com's FREE daily email newsletter.